Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | TNFb | 42.5 | 34 | |
N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | TNFb | 49.0 | 38 | |
N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | TNFb | 52.0 | 51 | |
N2586 | Sigma A6730 | 3.0 | uM | 1 | TNFb | 47.0 | 44 | ||||
RA2159 | IL-17A | 100 | ng/mL | 1 | TNFb | 50.0 | 62 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | TNFb | 44.0 | 66 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | TNFb | 37.0 | 52 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | TNFb | 36.0 | 63 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | TNFb | 37.0 | 60 | |
RA2159 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 1 | TNFb | 49.0 | 70 | |
N2586 | IL-17A | 100 | ng/mL | 1 | TNFb | 51.0 | 37 | ||||
N2586 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | TNFb | 51.0 | 37 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | TNFb | 94.0 | 28 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | TNFb | 55.0 | 31 | |
N2586 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | TNFb | 44.0 | 35 | |
N2586 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 1 | TNFb | 56.5 | 60 | |
RA2159 | 1 | TNFb | 44.0 | 55 | |||||||
RA2159 | PD184352 | 0.1 | uM | 1 | TNFb | 104.0 | 69 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 1 | TNFb | 59.0 | 51 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 1 | TNFb | 45.0 | 60 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 1 | TNFb | 43.0 | 57 | ||||
RA2159 | IKK16 | 2.0 | uM | 1 | TNFb | 40.0 | 50 | ||||
RA2159 | JNK-IN-8 | 3.0 | uM | 1 | TNFb | 44.0 | 43 | ||||
N2586 | 1 | TNFb | 38.0 | 63 | |||||||
N2586 | PD184352 | 0.1 | uM | 1 | TNFb | 44.0 | 54 |